HDHubert Dacyl

Hubert Dacyl

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hubert Dacyl has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnosis and management of finger injuries in sport climbers – narrative review with clinical and training implications

    by Piotr Widera, Hubert Bigajski, Maciej Michalik, Aleksandra Banaś, Dominika Sarna, Hubert Dacyl, Szymon Janczarski, Marcel Pilarek, Klaudia Kwolek, Wiktoria Laskowska

  • Open Access

    DIGITAL MENTAL HEALTH INTERVENTIONS: EFFECTIVENESS, ACCESSIBILITY, AND SOCIETAL IMPACT - A NARRATIVE REVIEW

    by Marcel Pilarek, Wiktoria Laskowska, Klaudia Kwolek, Hubert Bigajski, Aleksandra Banaś, Hubert Dacyl, Szymon Janczarski, Maciej Michalik, Dominika Sarna, Piotr Widera

    The escalating global mental health burden, affecting an estimated 165 million individuals annually within the European Union, necessitates a fundamental paradigm shift toward digitally-enhanced care models to alleviate systemic strain and limited provider availability. This narrative review provides a holistic socio-technical synthesis of the Digital Mental Health Interventions (DMHI) ecosystem, integrating heterogeneous evidence ranging from randomized controlled trials and meta-analyses to empirical technical software audits. Findings confirm the general non-inferiority of iCBT compared to traditional modalities, although therapeutic efficacy remains highly contingent upon human integration as defined by the Supportive Accountability model. While specialized tools like virtual reality demonstrate superior outcomes for PTSD, severe psychiatric conditions necessitate continued clinical oversight; crucially, a persistent engagement paradox exists wherein high initial adoption is frequently offset by significant long-term attrition. Structurally, the digital inverse care law and the digital divide reinforce systemic health disparities, excluding populations with infrastructure gaps or physical impairments. These systemic inequities are further compounded by an inverse data law, wherein algorithmic datasets remain biased toward healthy populations, leaving marginalized cohorts underrepresented. Furthermore, while digital platforms afford anonymity for managing stigmatized identities, they simultaneously expose vulnerable users to digital microaggressions and prejudice. Ultimately, rapid technological proliferation has outpaced regulatory governance, resulting in privacy vulnerabilities and profound regulatory fragmentation across jurisdictions. DMHI effectiveness is inextricably linked to socio-economic, cultural, and structural contexts, necessitating a transition toward regulated, clinically-led architectures to safeguard social equity and ensure genuine therapeutic value within the digital mental health transition.

  • Open Access

    DIGITAL MANAGEMENT OF HEART FAILURE IN AGING SOCIETIES: HEALTH SYSTEM TRANSFORMATION AND SOCIAL IMPLICATIONS - A NARRATIVE REVIEW

    by Wiktoria Laskowska, Marcel Pilarek, Klaudia Kwolek, Hubert Bigajski, Aleksandra Banaś, Hubert Dacyl, Szymon Janczarski, Maciej Michalik, Dominika Sarna, Piotr Widera

    Heart failure (HF) represents a multisystem syndromic challenge that imposes significant clinical and economic burdens on aging societies, with global costs estimated at US $284.17 billion. Conventional hospital-centered care paradigms are limited by episodic and reactive frameworks that frequently fail to detect physiological decompensation during critical post-discharge phases. This narrative review synthesizes evidence focusing primarily on the 2016-2026 period, while integrating foundational seminal studies dating back to 2006, to evaluate the interdisciplinary impact of digital health interventions on HF management. Empirical findings demonstrate a fundamental shift toward proactive, pathophysiology-driven care supported by remote patient monitoring, implantable sensors, and artificial intelligence. Key clinical outcomes include a hazard ratio of 0.80 for unplanned hospitalizations in landmark telemedical trials and a 92.5% diagnostic accuracy for neural network models. Organizationally, hybrid "Hospital-at-Home" models and transition-of-care coaching have demonstrated significant reductions in readmissions. This review concludes that a sustainable digital transformation is contingent upon achieving alignment between technological capability, longitudinal economic reimbursement models, and robust governance to resolve the technological equity (“Techquity”) divide affecting high-risk aging populations.

  • Open Access

    WEARABLE TECHNOLOGIES FOR ATRIAL FIBRILLATION: A NARRATIVE REVIEW OF DIAGNOSTIC ACCURACY, CLINICAL INTEGRATION, AND THE MANAGEMENT OF SILENT ARRHYTHMIAS

    by Szymon Janczarski, Aleksandra Banaś, Dominika Sarna, Piotr Widera, Maciej Michalik, Klaudia Kwolek, Marcel Pilarek, Wiktoria Laskowska, Filip Basta, Hubert Dacyl

    Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia worldwide and represents a major contributor to stroke, heart failure, and cardiovascular mortality. A significant proportion of AF cases remain asymptomatic, often referred to as "silent AF," which delays diagnosis and increases the risk of severe thromboembolic complications. Conventional diagnostic methods, including standard electrocardiography (ECG) and short-term Holter monitoring, are limited by their episodic nature and reliance on clinical settings, frequently failing to capture intermittent arrhythmic events. In recent years, consumer wearable technologies - particularly smartwatches equipped with photoplethysmography (PPG) sensors and single-lead ECG capabilities - have emerged as promising tools for continuous cardiac rhythm monitoring. This narrative review synthesizes contemporary evidence on the diagnostic accuracy, clinical integration, and behavioral implications of wearable technologies for AF detection. Literature published between 2018 and 2025 was identified through searches of PubMed/MEDLINE, Scopus, and Google Scholar. Studies evaluating sensing technologies, algorithmic approaches, large-scale population trials, and digital health behavior were included. Current evidence demonstrates that wearable devices can achieve high concordance with traditional ECG-based diagnostic methods, with many studies reporting sensitivities and specificities exceeding 90%. Passive PPG monitoring combined with user-initiated ECG confirmation enables scalable detection of previously undiagnosed AF in real-world settings. However, challenges remain, including signal artifacts, false-positive alerts, user adherence, and socioeconomic disparities in device access. Overall, wearable technologies represent a valuable adjunct for early AF detection and long-term rhythm monitoring. Their optimal clinical role lies within hybrid diagnostic pathways that integrate patient-generated data with physician validation and established cardiovascular care frameworks.

  • Open Access

    TELEMEDICINE IN CHRONIC DISEASE MANAGEMENT: CLINICAL EFFICACY, THE DIGITAL DIVIDE 2.0, AND IMPLEMENTATION REALITIES

    by Klaudia Kwolek, Marcel Pilarek, Wiktoria Laskowska, Hubert Bigajski, Dominika Sarna, Piotr Widera, Szymon Janczarski, Maciej Michalik, Aleksandra Banaś, Hubert Dacyl

    As chronic non-communicable diseases (NCDs) reach epidemic proportions globally, traditional episodic care models remain insufficient, necessitating a shift toward continuous, technology-driven management. This narrative review critically assesses the clinical utility of telemedicine interventions—specifically continuous glucose monitoring, remote hypertension surveillance, and implantable hemodynamic sensors—while examining the persistent socio-technical barriers impeding their widespread adoption. Based on a comprehensive synthesis of literature from PubMed/MEDLINE, Scopus, and Google Scholar (2020–2025), this study contrasts clinical efficacy with implementation realities. The evidence confirms that while telemedical tools consistently surpass conventional care in stabilizing metabolic control and lowering hospitalization rates, their long-term viability is compromised by the "Digital Divide 2.0"—a phenomenon defined by deficits in digital literacy and usability challenges among the elderly. Moreover, the analysis identifies systemic bottlenecks, including fragmented data standardization and the exclusion of patient-generated health data from routine workflows. Ethical tensions surrounding algorithmic paternalism and surveillance fatigue are also highlighted as critical factors affecting patient autonomy. Ultimately, bridging the gap between digital capability and sustainable practice requires moving beyond technological determinism toward a holistic strategy that integrates policy innovation, human-centered design, and ethical data governance.

  • Open Access

    Teprotumumab as a Breakthrough in Thyroid Eye Disease Therapy: A Comprehensive Review

    by Marceli Mesyasz, Mateusz Piszka, Eliza Kwapień, Hubert Dacyl, Aleksandra Owczarska, Julia Żerdka, Patryk Brasse, Jan Banach, Jakub Bartkowski, Filip Czarnecki

    Background. Thyroid Eye Disease (TED) is a complex autoimmune condition associated with Graves' disease, causing disfigurement, visual impairment, and reduced quality of life. For decades, options were limited to non-specific anti-inflammatory treatments like glucocorticosteroids and radiotherapy, often failing to address symptoms like proptosis and diplopia. Identifying the insulin-like growth factor-1 receptor (IGF-1R) as a driver of TED pathophysiology led to targeted therapies.Aim. This study reviews teprotumumab as a breakthrough TED therapy, analyzing its mechanism, efficacy, and place in treatment algorithms relative to traditional methods.Material and methodsA literature review was conducted using databases (PubMed, Embase, ClinicalTrials.gov) for articles up to November 2025. Analysis prioritized pivotal trials (OPTIC, OPTIC-X), meta-analyses, and reviews focusing on TED pathophysiology and IGF-1R inhibition.Results. TED pathogenesis involves crosstalk between TSHR and IGF-1R on orbital fibroblasts, triggering inflammation and adipogenesis. While traditional treatments offer limited relief with side effects, teprotumumab, the first FDA-approved IGF-1R inhibitor, targets these mechanisms. Clinical data shows superior efficacy in reducing proptosis and improving diplopia compared to palliative care.Conclusions. Teprotumumab is a breakthrough in TED management, shifting from symptomatic to targeted disease modification. By addressing orbital remodeling causes, it offers distinct advantages over traditional therapies, fulfilling a major unmet need.

  • Open Access

    The impact of sleep duration and quality on the health of the pediatric population: consequences for mental health, eating disorders, and other diseases

    by Jakub Bartkowski, Julia Żerdka, Patryk Brasse, Jan Banach, Hubert Dacyl, Aleksandra Owczarska, Mateusz Piszka, Eliza Kwapień, Marceli Mesyasz

    Background Sleep is a fundamental biological process, the duration and quality of which are of key importance for the proper development and health of the pediatric population. Understanding the complex relationship between sleep and the pathogenesis of diseases during childhood is essential for developing effective preventive and interventional strategies aimed at supporting the holistic health of the youngest patients. Aim This review aims to provide an analysis of available scientific evidence regarding the impact of insufficient sleep duration and poor sleep quality on a wide range of health indicators in children and adolescents. Special emphasis is placed on the consequences for mental health and eating disorders. Materials and methods This review synthesizes current evidence by examining literature available on PubMed, Google Scholar, and academic sources using keywords related to the sleep duration, sleep quality, pediatric population, mental health and eating disorders. Experimental, cohort, systematic reviews and clinical studies were evaluated. Results We highlight sex- and age-dependent vulnerabilities and discuss the multifactorial interplay between sleep behavior, lifestyle factors, and disease risk.Specifically, interventions aimed at improving sleep hygiene, reducing screen exposure before bedtime, and addressing sleep disorders such as obstructive sleep apnea show promise in mitigating risks associated with obesity, hypertension, emotional disorders, and chronic inflammation. Conclusion Sleep duration and sleep quality contributes to pediatric obesity, insulin resistance, cardiometabolic risk, mental health, inflammatory processes and headache disorders. Limitations in current research, including methodological heterogeneity and reliance on subjective sleep measures, underscore the need for prospective studies. We recommend future research focus on mechanistic pathways linking sleep disturbances to specific health outcomes.

  • Open Access

    The influence of the microbiome on the development and course of bronchial asthma – a comprehensive review

    by Hubert Dacyl, Aleksandra Owczarska, Julia Żerdka, Patryk Brasse, Mateusz Piszka, Eliza Kwapień, Jan Banach, Jakub Bartkowski, Marceli Mesyasz

    Background Asthma is a chronic airway disease increasingly linked to alterations in the human microbiome. Early-life disruptions in gut, airway, and skin microbiota are associated with impaired immune maturation and higher susceptibility to asthma and allergies. Aim The aim of this study is to review current knowledge on how the human microbiome influences the development, course, and severity of bronchial asthma, including its role in immune regulation, asthma phenotypes, the gut-lung axis, and potential microbiome-based therapies. Materials and Methods This review integrates current evidence using literature from PubMed, Google Scholar, and academic texts with keywords related to the microbiome, gut–lung axis, asthma, dysbiosis, and microbiome-targeted interventions. Experimental, cohort, and clinical studies were analysed. Results The microbiome plays a crucial role in asthma development, especially early in life. Microbial composition is shaped by delivery mode, breastfeeding, antibiotic exposure, and environmental diversity. Cesarean delivery and persistent dysbiosis increase asthma risk, while breastfeeding promotes protective profiles. Early gut dysbiosis - such as reduced SCFA-producing bacteria - affects immune maturation and contributes to distinct asthma phenotypes. Airway colonization by Proteobacteria (e.g., Haemophilus, Moraxella) is associated with severe disease, steroid resistance, and frequent exacerbations. Microbiome-targeted strategies, including probiotics, postbiotics, and fecal microbiota transplantation, show therapeutic potential. Conclusions The microbiome is a key regulator of immune development and a major contributor to asthma risk. Microbiome-based interventions are promising but require further well-designed clinical research.

  • Open Access

    The Role of Creatine Supplementation in Cardiovascular Health: A Comprehensive Review

    by Aleksandra Owczarska, Julia Dołęga, Piotr Mól, Hubert Dacyl, Martyna Laskowska, Michał Pasiut, Barbara Lew

    Background Creatine is a compound synthesized in the human body, but it can also be obtained from food sources. Research demonstrates that creatine supplementation is safe, provides long-term benefits, and has therapeutic potential. Aim This study aims to present current knowledge regarding the role of creatine in the human body, with a particular focus on the effects of creatine supplementation on the cardiovascular system. Materials and Methods A comprehensive literature review was conducted across PubMed, Google Scholar, and relevant academic texts. Keywords included "creatine," "supplementation," "cardiovascular diseases," and "heart failure." Results In the human body, creatine is transported through the bloodstream and absorbed by energy-demanding cells. It supports muscle recovery and increases lean body mass, making it beneficial in tendon injury rehabilitation. Regarding cardiovascular health, some studies suggest that creatine supplementation lowers systolic blood pressure, enhances microcirculation, reduces homocysteine levels, and decreases inflammation by inhibiting markers like TNF-α and CRP. However, other studies indicate minimal impact on blood flow, lipid profiles, and hemodynamic parameters. Conclusions Creatine exhibits wide-ranging properties, positioning it as a strong candidate for further research and a potential therapeutic agent, though further research is needed to clarify its cardiovascular effects.